Webinar: The RNAscope™ ISH Breakthrough: When Clarity Matters - A Leica-ACD Sponsored Webinar, Hosted by Pathology News

In this roundtable discussion, pathologists Dr. Monroe and Dr. Laser provide an overview of RNAscope ISH technology and how it is shaping the molecular in situ hybridization (ISH) testing landscape. 

You will see how RNAscope RNA ISH, coupled with automation capability on the Leica Biosystems BOND platform, takes ISH to the next level. Through their discussion, you will see how the technology allows for highly specific target recognition and amplification of RNA signals.

• Understand the significance of ISH and its traditional role in diagnostic testing as a valuable tool for obtaining a comprehensive diagnostic picture.
• Learn about the evolution of ISH, focusing on how RNAscope technology has successfully progressed the capabilities of traditional ISH through its potential to provide higher sensitivity and specificity in RNA detection.
• See the ISH difference for yourself as RNAscope is put into context and comes alive with slide images.

Panelists:

Jordan Laser, MD, is a board-certified pathologist specializing in anatomic, clinical, and molecular genetics, currently leading clinical and medical affairs at Bio-Techne, with extensive experience in molecular medicine and lab management.

Robert Monroe, MD, PhD, is a board-certified pathologist and geneticist, serving as VP and Chief Scientific Officer of Oncology at Danaher Diagnostics and CMO at Leica Biosystems, with a background in molecular oncology and co-founding OncoMDx.